市場調査レポート

商品コード

動物用感染症診断薬の世界市場：製品別、技術別、動物タイプ別、エンドユーザー別、地域別 - 2030年までの予測

Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030

出版日: 2025年08月13日
発行: MarketsandMarkets
ページ情報: 英文 548 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 4,950 736,213円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (5-user License)

USD 6,650 989,054円

レポートPDFを同じ国内の同じ事業所内の5名迄にて共有ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Corporate License)

USD 8,150 1,212,149円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありませんが、同一国内にある事業所のみとなり、海外支店などは含まれません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Global License)

USD 10,000 1,487,300円

レポートPDFを同一企業の全世界の方にご使用頂けるライセンスです。ご利用人数に制限はありません。100％子会社は同一企業とみなされます。PDF内のテキスト等のコピー＆ペースト可能です。PDの印刷は何回でも可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.73円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

動物用感染症診断薬の市場規模は、2025年の28億7,000万米ドルから2030年には42億2,000万米ドルに成長し、CAGRは8.0％になると予測されています。

この成長は、動物の健康と疾病管理の変化を反映するいくつかの重要な要因によってもたらされます。

調査範囲
調査対象年	2024年～2030年
基準年	2024年
予測期間	2025年～2030年
検討単位	金額（10億米ドル）
セグメント別	製品別、技術別、動物タイプ別、エンドユーザー別、地域別
対象地域	北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ

コンパニオンアニマルや家畜の間で感染症の負担が増加していることが、迅速で信頼性が高く、現場展開可能な診断ソリューションの必要性を高めています。鳥インフルエンザ、レプトスピラ症、ブルセラ症などの疾病の発生増加により、獣医師や動物生産者はリスクを軽減するために早期かつ正確な検出を優先するようになっています。

Veterinary Infectious Disease Diagnostics Market-IMG1

もう一つの重要な要因は、予防的動物医療へのシフトです。ペットの飼い主や家畜を扱う人々の意識が高まるにつれ、感染が拡大する前に特定するための定期的な検査や健康モニタリングが重視されるようになっています。この動向は、人獣共通感染症の伝播に伴う経済的・公衆衛生的影響に対する認識の高まりにも支えられています。

コンパニオンアニマルセグメンテーションは、特に都市部の高所得世帯におけるペット飼育の増加により、動物用感染症診断薬市場で最も高い成長が見込まれています。ペットの飼い主は、人獣共通感染症に対する意識の高まりや早期発見の重要性から、健康診断や診断サービスへの投資に積極的です。さらに、ポイント・オブ・ケアや在宅診断ツールの技術革新により、ペットの飼い主と獣医師の双方にとってのアクセスが向上しています。動物病院を訪れる頻度が増え、ペットのヘルスケア支出が増加していることから、この分野は市場の急成長が予測されます。

2024年、動物用感染症診断市場は、費用対効果と精度の高さから、免疫診断分野が優位を占めました。ELISAやラテラルフローアッセイのような技術は、コンパニオンアニマルや家畜動物の様々な感染症を検出するために一般的に使用されています。これらの検査は迅速な結果が得られ、使い勝手が良く、最小限の設備で済むため、動物病院や現場での使用に理想的です。特定の抗原や抗体を検出する能力は、早期診断と効果的な疾病管理を可能にし、大規模な集団スクリーニングや日常的な監視プログラムにとって貴重なものとなっています。

アジア太平洋は、様々な人口動態、経済、ヘルスケア要因により、動物用伝染病診断薬市場で最も高い成長を遂げると見られています。この地域は畜産人口が多いため、口蹄疫や鳥インフルエンザなどの感染症の増加に対処するための正確な診断薬に対する需要が高まっています。さらに、特に中国とインドの都市部ではコンパニオンアニマル（伴侶動物）の数が増加しており、動物医療ヘルスケア支出を押し上げています。動物医療インフラの強化、人獣共通感染症の脅威に対する意識の高まり、動物衛生への投資も市場成長に寄与しています。企業は高度な診断技術へのアクセスを向上させるため、この地域でのプレゼンスを拡大しています。

当レポートでは、世界の動物用感染症診断薬市場について調査し、製品別、技術別、動物タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

市場力学
業界動向
技術分析
ポーターのファイブフォース分析
規制分析
特許分析
貿易分析
価格分析
償還分析
2025年～2026年の主な会議とイベント
主要な利害関係者と購入基準
エンドユーザーの視点とアンメットニーズ
動物用感染症診断薬市場におけるAIの影響
エコシステム分析
バリューチェーン分析
サプライチェーン分析
隣接市場分析
投資と資金調達のシナリオ
2025年の米国関税が動物用感染症診断薬市場に与える影響

第6章動物用感染症診断薬市場（製品別）

イントロダクション
消耗品
機器

第7章動物用感染症診断薬市場（技術別）

イントロダクション
免疫診断
分子診断
その他

第8章動物用感染症診断薬市場（動物タイプ別）

イントロダクション
コンパニオンアニマル
家畜

第9章動物用感染症診断薬市場（エンドユーザー別）

イントロダクション
獣医学参照試験所
動物病院・クリニック
ポイントオブケア/社内検査
獣医学研究機関および大学

第10章動物用感染症診断薬市場（地域別）

イントロダクション
北米
- 北米のマクロ経済見通し
- 米国
- カナダ
欧州
- 欧州のマクロ経済見通し
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- オランダ
- その他
アジア太平洋
- アジア太平洋のマクロ経済見通し
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- ニュージーランド
- ベトナム
- その他
ラテンアメリカ
- ラテンアメリカのマクロ経済見通し
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 中東・アフリカのマクロ経済見通し
- GCC諸国
- その他

第11章競合情勢

概要
主要参入企業の戦略/強み
収益分析、2020年～2024年
市場シェア分析、2024年
企業評価マトリックス：主要参入企業、2024年
企業評価マトリックス：スタートアップ/中小企業、2024年
ブランド/製品比較
主要企業の研究開発費
企業評価と財務指標
競合シナリオ

第12章企業プロファイル

主要参入企業
- IDEXX LABORATORIES, INC.
- ZOETIS SERVICES LLC
- THERMO FISHER SCIENTIFIC INC.
- VIRBAC
- BIOMERIEUX
- ANTECH DIAGNOSTICS, INC.
- INNOVATIVE DIAGNOSTICS
- NEOGEN CORPORATION
- INDICAL BIOSCIENCE GMBH
- AGROLABO S.P.A.
- BIONOTE
- BIOGAL
- BIOCHEK
- MEGACOR DIAGNOSTIK GMBH
- BIO-RAD LABORATORIES, INC.
その他の企業
- FASSISI, GMBH
- BIOTANGENTS LIMITED
- SKYER, INC.
- BIOPANDA REAGENTS LTD.
- SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
- GOLD STANDARD DIAGNOSTICS
- BIO-X DIAGNOSTICS S.A.
- DEMEDITEC DIAGNOSTICS GMBH
- EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
- BIOSTONE ANIMAL HEALTH

第13章付録

図表

List of Tables

TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
TABLE 2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS
TABLE 3 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
TABLE 4 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS)
TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009-2023)
TABLE 6 AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023
TABLE 7 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012-2023) (USD MILLION)
TABLE 8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: MAJOR PATENTS
TABLE 13 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020-2023 (USD THOUSAND)
TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020-2023 (USD THOUSAND)
TABLE 15 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022-2024
TABLE 16 AVERAGE SELLING PRICE TREND OF ELISA TEST KITS (PER 96-WELL KIT), BY REGION, 2022-2024
TABLE 17 AVERAGE SELLING PRICE TREND OF LATERAL FLOW RAPID TESTS (PER UNIT), BY REGION, 2022-2024
TABLE 18 AVERAGE SELLING PRICE TREND OF PCR TEST KITS (VETERINARY PANELS), BY REGION, 2022-2024
TABLE 19 AVERAGE SELLING PRICE TREND OF IMMUNOASSAY ANALYZER (BENCHTOP), BY REGION, 2022-2024
TABLE 20 AVERAGE SELLING PRICE TREND OF HIGH-END IMMUNOASSAY ANALYZERS, BY REGION, 2022-2024
TABLE 21 AVERAGE SELLING PRICE TREND OF NUCLEIC ACID SEQUENCERS (BENCHTOP) BY REGION, 2022-2024
TABLE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025-2026
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS (%)
TABLE 24 KEY BUYING CRITERIA FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
TABLE 25 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
TABLE 26 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 28 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
TABLE 29 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
TABLE 30 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
TABLE 31 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
TABLE 32 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
TABLE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 34 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 35 KEY PLAYERS OFFERING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC CONSUMABLES
TABLE 36 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 37 KEY PLAYERS PROVIDING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC INSTRUMENTS
TABLE 38 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 39 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 40 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
TABLE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 42 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 43 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS
TABLE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2023-2030 (THOUSAND UNITS)
TABLE 45 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 47 KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS
TABLE 48 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW RAPID TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 49 KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS
TABLE 50 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW STRIP READERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 51 KEY PLAYERS PROVIDING ELISA TESTS
TABLE 52 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY REGION, 2023-2030 (THOUSAND UNITS)
TABLE 53 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 54 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS
TABLE 55 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2023-2030 (THOUSAND UNITS)
TABLE 56 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 57 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
TABLE 58 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 59 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC TESTS
TABLE 60 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 61 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 62 KEY PLAYERS PROVIDING PCR TESTS
TABLE 63 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY REGION, 2023-2030 (THOUSAND UNITS)
TABLE 64 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 65 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING
TABLE 66 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY REGION, 2023-2030 (THOUSAND UNITS)
TABLE 67 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 68 KEY PLAYERS PROVIDING MICROARRAYS
TABLE 69 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY REGION, 2023-2030 (THOUSAND UNITS)
TABLE 70 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 71 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
TABLE 72 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 73 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES
TABLE 74 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 75 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 76 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR COMPANION ANIMALS
TABLE 77 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 78 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 79 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR DOGS
TABLE 80 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 81 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATS
TABLE 82 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 83 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR HORSES
TABLE 84 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 85 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER COMPANION ANIMALS
TABLE 86 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 87 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 88 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 89 COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 90 COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 91 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR COMPANION ANIMALS
TABLE 92 COMPANION ANIMALS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 93 KEY PLAYERS PROVIDING ELISA TESTS FOR COMPANION ANIMALS
TABLE 94 COMPANION ANIMALS MARKET FOR ELISA TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 95 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR COMPANION ANIMALS
TABLE 96 COMPANION ANIMALS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 97 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 98 COMPANION ANIMALS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 99 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR COMPANION ANIMALS
TABLE 100 COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 101 COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 102 KEY PLAYERS PROVIDING PCR TESTS FOR COMPANION ANIMALS
TABLE 103 COMPANION ANIMALS MARKET FOR PCR TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 104 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR COMPANION ANIMALS
TABLE 105 COMPANION ANIMALS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 106 KEY PLAYERS PROVIDING MICROARRAYS FOR COMPANION ANIMALS
TABLE 107 COMPANION ANIMALS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 108 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 109 COMPANION ANIMALS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 110 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 111 COMPANION ANIMALS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 112 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR LIVESTOCK
TABLE 113 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 114 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 115 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATTLE
TABLE 116 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 117 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR PIGS
TABLE 118 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 119 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR POULTRY
TABLE 120 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 121 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER LIVESTOCK ANIMALS
TABLE 122 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 123 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 124 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
TABLE 125 LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 126 LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 127 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR LIVESTOCK
TABLE 128 LIVESTOCK MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 129 KEY PLAYERS PROVIDING ELISA TESTS FOR LIVESTOCK
TABLE 130 LIVESTOCK MARKET FOR ELISA TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 131 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR LIVESTOCK
TABLE 132 LIVESTOCK MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 133 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
TABLE 134 LIVESTOCK MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 135 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR LIVESTOCK
TABLE 136 LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 137 LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 138 KEY PLAYERS PROVIDING PCR TESTS FOR LIVESTOCK
TABLE 139 LIVESTOCK MARKET FOR PCR TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 140 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR LIVESTOCK
TABLE 141 LIVESTOCK MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 142 KEY PLAYERS PROVIDING MICROARRAYS FOR LIVESTOCK
TABLE 143 LIVESTOCK MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 144 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
TABLE 145 LIVESTOCK MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 146 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR LIVESTOCK
TABLE 147 LIVESTOCK MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 148 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 149 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 150 BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US, 2023 (USD)
TABLE 151 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 152 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 153 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 154 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 155 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 156 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 157 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 158 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 159 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 160 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 161 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 162 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 163 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 164 NORTH AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 165 NORTH AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 166 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 167 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 168 NORTH AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 169 NORTH AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 170 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 171 US: KEY MACROINDICATORS
TABLE 172 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 173 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 174 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 175 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 176 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 177 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 178 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 179 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 180 US: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 181 US: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 182 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 183 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 184 US: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 185 US: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 186 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 187 CANADA: KEY MACROINDICATORS
TABLE 188 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 189 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 190 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 191 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 192 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 193 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 194 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 195 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 196 CANADA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 197 CANADA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 198 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 199 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 200 CANADA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 201 CANADA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 202 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 203 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 204 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 205 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 206 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 207 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 208 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 209 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 210 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 211 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 212 EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 213 EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 214 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 215 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 216 EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 217 EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 218 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 219 GERMANY: KEY MACROINDICATORS
TABLE 220 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 221 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 222 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 223 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 224 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 225 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 226 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 227 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 228 GERMANY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 229 GERMANY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 230 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 231 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 232 GERMANY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 233 GERMANY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 234 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 235 UK: KEY MACROINDICATORS
TABLE 236 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 237 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 238 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 239 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 240 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 241 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 242 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 243 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 244 UK: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 245 UK: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 246 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 247 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 248 UK: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 249 UK: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 250 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 251 FRANCE: KEY MACROINDICATORS
TABLE 252 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 253 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 254 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 255 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 256 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 257 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 258 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 259 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 260 FRANCE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 261 FRANCE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 262 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 263 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 264 FRANCE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 265 FRANCE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 266 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 267 ITALY: KEY MACROINDICATORS
TABLE 268 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 269 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 270 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 271 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 272 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 273 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 274 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 275 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 276 ITALY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 277 ITALY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 278 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 279 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 280 ITALY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 281 ITALY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 282 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 283 SPAIN: KEY MACROINDICATORS
TABLE 284 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 285 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 286 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 287 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 288 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 289 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 290 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 291 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 292 SPAIN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 293 SPAIN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 294 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 295 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 296 SPAIN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 297 SPAIN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 298 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 299 NETHERLANDS: KEY MACROINDICATORS
TABLE 300 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 301 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 302 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 303 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 304 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 305 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 306 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 307 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 308 NETHERLANDS: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 309 NETHERLANDS: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 310 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 311 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 312 NETHERLANDS: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 313 NETHERLANDS: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 314 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 315 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 316 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 317 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 318 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 319 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 320 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 321 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 322 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 323 REST OF EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 324 REST OF EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 325 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 326 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 327 REST OF EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 328 REST OF EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 329 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 330 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 331 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 332 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 333 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 334 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 335 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 336 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 337 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 338 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 339 ASIA PACIFIC: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 340 ASIA PACIFIC: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 341 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 342 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 343 ASIA PACIFIC: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 344 ASIA PACIFIC: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 345 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 346 CHINA: KEY MACROINDICATORS
TABLE 347 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 348 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 349 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 350 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 351 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 352 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 353 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 354 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 355 CHINA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 356 CHINA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 357 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 358 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 359 CHINA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 360 CHINA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 361 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 362 JAPAN: KEY MACROINDICATORS
TABLE 363 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 364 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 365 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 366 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 367 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 368 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 369 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 370 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 371 JAPAN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 372 JAPAN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 373 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 374 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 375 JAPAN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 376 JAPAN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 377 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 378 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 379 INDIA: KEY MACROINDICATORS
TABLE 380 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 381 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 382 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 383 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 384 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 385 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 386 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 387 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 388 INDIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 389 INDIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 390 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 391 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 392 INDIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 393 INDIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 394 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 395 AUSTRALIA: KEY MACROINDICATORS
TABLE 396 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 397 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 398 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 399 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 400 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 401 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 402 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 403 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 404 AUSTRALIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 405 AUSTRALIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 406 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 407 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 408 AUSTRALIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 409 AUSTRALIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 410 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 411 SOUTH KOREA: KEY MACROINDICATORS
TABLE 412 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 413 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 414 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 415 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 416 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 417 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 418 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 419 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 420 SOUTH KOREA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 421 SOUTH KOREA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 422 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 423 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 424 SOUTH KOREA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 425 SOUTH KOREA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 426 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 427 NEW ZEALAND: KEY MACROINDICATORS
TABLE 428 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 429 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 430 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 431 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 432 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 433 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 434 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 435 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 436 NEW ZEALAND: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 437 NEW ZEALAND: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 438 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 439 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 440 NEW ZEALAND: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 441 NEW ZEALAND: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 442 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 443 VIETNAM: KEY MACROINDICATORS
TABLE 444 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 445 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 446 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 447 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 448 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 449 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 450 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 451 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 452 VIETNAM: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 453 VIETNAM: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 454 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 455 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 456 VIETNAM: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 457 VIETNAM: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 458 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 459 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 460 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 461 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 462 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 463 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 464 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 465 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 466 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 467 REST OF ASIA PACIFIC: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 468 REST OF ASIA PACIFIC: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 469 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 470 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 471 REST OF ASIA PACIFIC: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 472 REST OF ASIA PACIFIC: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 473 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 474 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 475 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 476 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 477 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 478 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 479 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 480 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 481 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 482 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 483 LATIN AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 484 LATIN AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 485 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 486 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 487 LATIN AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 488 LATIN AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 489 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 490 BRAZIL: KEY MACROINDICATORS
TABLE 491 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 492 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 493 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 494 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 495 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 496 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 497 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 498 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 499 BRAZIL: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 500 BRAZIL: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 501 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 502 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 503 BRAZIL: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 504 BRAZIL: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 505 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 506 MEXICO: KEY MACROINDICATORS
TABLE 507 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 508 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 509 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 510 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 511 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 512 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 513 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 514 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 515 MEXICO: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 516 MEXICO: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 517 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 518 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 519 MEXICO: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 520 MEXICO: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 521 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 522 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 523 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 524 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 525 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 526 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 527 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 528 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 529 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 530 REST OF LATIN AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 531 REST OF LATIN AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 532 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 533 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 534 REST OF LATIN AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 535 REST OF LATIN AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 536 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 537 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 538 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 539 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 540 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 541 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 542 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 543 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 544 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 545 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 546 MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 547 MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 548 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 549 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 550 MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, B Y TYPE, 2023-2030 (USD MILLION)
TABLE 551 MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 552 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 553 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 554 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 555 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 556 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 557 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 558 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 559 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 560 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 561 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 562 GCC COUNTRIES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 563 GCC COUNTRIES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 564 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 565 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 566 GCC COUNTRIES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 567 GCC COUNTRIES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 568 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 569 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
TABLE 570 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 571 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 572 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 573 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 574 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 575 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 576 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 577 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 578 KINGDOM OF SAUDI ARABIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 579 KINGDOM OF SAUDI ARABIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 580 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 581 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 582 KINGDOM OF SAUDI ARABIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 583 KINGDOM OF SAUDI ARABIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 584 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 585 UNITED ARAB EMIRATES: KEY MACROINDICATORS
TABLE 586 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 587 UNITED ARAB EMIRATES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 588 UNITED ARAB EMIRATES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 589 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 590 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 591 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 592 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 593 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 594 UNITED ARAB EMIRATES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 595 UNITED ARAB EMIRATES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 596 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 597 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 598 UNITED ARAB EMIRATES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 599 UNITED ARAB EMIRATES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 600 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 601 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 602 REST OF GCC COUNTRIES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 603 REST OF GCC COUNTRIES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 604 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 605 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 606 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 607 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 608 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 609 REST OF GCC COUNTRIES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 610 REST OF GCC COUNTRIES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 611 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 612 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 613 REST OF GCC COUNTRIES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 614 REST OF GCC COUNTRIES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 615 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 616 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 617 REST OF MIDDLE EAST & AFRICA : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 618 REST OF MIDDLE EAST & AFRICA : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 619 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 620 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 621 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
TABLE 622 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 623 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 624 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 625 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 626 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
TABLE 627 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 628 REST OF MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 629 REST OF MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 630 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 631 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 632 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS: DEGREE OF COMPETITION
TABLE 633 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK: DEGREE OF COMPETITION
TABLE 634 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGION FOOTPRINT
TABLE 635 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PRODUCT FOOTPRINT
TABLE 636 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT
TABLE 637 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT
TABLE 638 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 639 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS
TABLE 640 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2025
TABLE 641 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEALS, JANUARY 2022-MAY 2025
TABLE 642 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022-MAY 2025
TABLE 643 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
TABLE 644 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 645 IDEXX LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 646 IDEXX LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2025
TABLE 647 ZOETIS SERVICES LLC: COMPANY OVERVIEW
TABLE 648 ZOETIS SERVICES LLC: PRODUCTS & SERVICES OFFERED
TABLE 649 ZOETIS SERVICES LLC: PRODUCT ENHANCEMENTS, JANUARY 2022-MAY 2025
TABLE 650 ZOETIS SERVICES LLC: DEALS, JANUARY 2022-APRIL 2025
TABLE 651 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022-MAY 2025
TABLE 652 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 653 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
TABLE 654 VIRBAC: COMPANY OVERVIEW
TABLE 655 VIRBAC: PRODUCTS & SERVICES OFFERED
TABLE 656 VIRBAC: DEALS, JANUARY 2022-MAY 2025
TABLE 657 VIRBAC: EXPANSIONS, JANUARY 2022-MAY 2025
TABLE 658 BIOMERIEUX: COMPANY OVERVIEW
TABLE 659 BIOMERIEUX: PRODUCTS & SERVICES OFFERED
TABLE 660 BIOMERIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2025
TABLE 661 ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW
TABLE 662 ANTECH DIAGNOSTICS, INC.: PRODUCTS & SERVICES OFFERED
TABLE 663 ANTECH DIAGNOSTICS, INC.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
TABLE 664 ANTECH DIAGNOSTICS, INC.: EXPANSIONS, JANUARY 2022-MAY 2025
TABLE 665 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
TABLE 666 INNOVATIVE DIAGNOSTICS: PRODUCTS & SERVICES OFFERED
TABLE 667 NEOGEN CORPORATION: COMPANY OVERVIEW
TABLE 668 NEOGEN CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 669 NEOGEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
TABLE 670 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
TABLE 671 INDICAL BIOSCIENCE GMBH: PRODUCTS & SERVICES OFFERED
TABLE 672 INDICAL BIOSCIENCE GMBH: PRODUCT ENHANCEMENTS, JANUARY 2022-MAY 2025
TABLE 673 AGROLABO S.P.A.: COMPANY OVERVIEW
TABLE 674 AGROLABO S.P.A.: PRODUCTS & SERVICES OFFERED
TABLE 675 BIONOTE: COMPANY OVERVIEW
TABLE 676 BIONOTE: PRODUCTS & SERVICES OFFERED
TABLE 677 BIONOTE: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
TABLE 678 BIONOTE: DEALS, JANUARY 2022-MAY 2025
TABLE 679 BIOGAL: COMPANY OVERVIEW
TABLE 680 BIOGAL: PRODUCTS & SERVICES OFFERED
TABLE 681 BIOCHEK: COMPANY OVERVIEW
TABLE 682 BIOCHEK: PRODUCTS & SERVICES OFFERED
TABLE 683 BIOCHEK: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
TABLE 684 BIOCHEK: DEALS, JANUARY 2022-MAY 2025
TABLE 685 MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW
TABLE 686 MEGACOR DIAGNOSTIK GMBH: PRODUCTS & SERVICES OFFERED
TABLE 687 MEGACOR DIAGNOSTIK GMBH: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2025
TABLE 688 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 689 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 690 FASSISI, GMBH: COMPANY OVERVIEW
TABLE 691 BIOTANGENTS LIMITED: COMPANY OVERVIEW
TABLE 692 SKYER, INC.: COMPANY OVERVIEW
TABLE 693 BIOPANDA REAGENTS LTD.: COMPANY OVERVIEW
TABLE 694 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 695 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW
TABLE 696 BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW
TABLE 697 DEMEDITEC DIAGNOSTICS GMBH: COMPANY OVERVIEW
TABLE 698 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: COMPANY OVERVIEW
TABLE 699 BIOSTONE ANIMAL HEALTH: COMPANY OVERVIEW

List of Figures

FIGURE 1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 9 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2024)
FIGURE 10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2025-2030)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 TOP-DOWN APPROACH
FIGURE 14 BOTTOM-UP APPROACH
FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 17 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 18 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 19 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 20 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 21 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 23 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 24 GEOGRAPHIC SNAPSHOT OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
FIGURE 25 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO FUEL MARKET GROWTH
FIGURE 26 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES IN 2024
FIGURE 27 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 28 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 29 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 30 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 31 EUROPE: PET POPULATION, 2021-2023
FIGURE 32 US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD)
FIGURE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 34 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014-MAY 2025)
FIGURE 35 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2014-MAY 2025)
FIGURE 36 AVERAGE SELLING PRICE TREND FOR ELISA TEST KITS AND PCR TEST KITS, BY KEY PLAYER, 2024
FIGURE 37 AVERAGE SELLING PRICE OF ELISA AND PCR TEST KITS, BY REGION, 2024
FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
FIGURE 39 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 40 AI USE CASES
FIGURE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
FIGURE 42 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 43 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ADJACENT MARKETS
FIGURE 45 INVESTMENT AND FUNDING SCENARIO FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET PLAYERS, 2020-2024
FIGURE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 47 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012-2030
FIGURE 48 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIGURE 49 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 50 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 51 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIGURE 52 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020-2024)
FIGURE 53 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS (2024)
FIGURE 54 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK (2024)
FIGURE 55 RANKING OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2024
FIGURE 56 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 57 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY FOOTPRINT
FIGURE 58 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 59 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 60 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2022-2024
FIGURE 61 EV/EBITDA OF KEY VENDORS
FIGURE 62 YEAR-TO-DATE (YTD) PRICE OF TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 63 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 64 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024)
FIGURE 65 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 66 VIRBAC: COMPANY SNAPSHOT (2024)
FIGURE 67 BIOMERIEUX: COMPANY SNAPSHOT (2024)
FIGURE 68 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 69 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)

Product Code: MD 7211

The veterinary infectious disease diagnostics market is expected to grow from USD 2.87 billion in 2025 to USD 4.22 billion by 2030, at a CAGR of 8.0%. This growth is driven by several important factors that reflect the changing landscape of animal health and disease management.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD billion)
Segments	By Product, Technology, Animal Type, End User, Region
Regions covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

One primary driver is the increasing burden of infectious diseases among both companion animals and livestock, which has heightened the need for rapid, reliable, and field-deployable diagnostic solutions. The rise in outbreaks of diseases such as avian influenza, leptospirosis, and brucellosis is leading veterinarians and animal producers to prioritize early and accurate detection to mitigate risks.

Another significant factor is the shift towards preventive veterinary care. As awareness grows among pet owners and livestock handlers, there is a stronger emphasis on routine screenings and health monitoring to identify infections before they escalate. This trend is also supported by a growing recognition of the economic and public health consequences associated with the transmission of zoonotic diseases.

"By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period."

The companion animals segment is expected to see the highest growth in the veterinary infectious disease diagnostics market, driven by increasing pet ownership, especially in urban high-income households. Pet owners are more willing to invest in health check-ups and diagnostic services due to the growing awareness of zoonotic diseases and the importance of early detection. Additionally, innovations in point-of-care and home-based diagnostic tools enhance access for both pet owners and veterinarians. With more frequent visits to veterinary clinics and rising healthcare spending for pets, this segment is projected for rapid growth in the market.

"By technology, the immunodiagnostics segment accounted for the largest market share in 2024."

In 2024, the immunodiagnostics segment dominated the veterinary infectious disease diagnostics market due to its cost-effectiveness and high accuracy. Techniques like ELISA and lateral flow assays are commonly used to detect various infectious diseases in companion and livestock animals. These tests provide rapid results, are user-friendly, and require minimal equipment, making them ideal for veterinary clinics and field use. Their ability to detect specific antigens or antibodies enables early diagnosis and effective disease management, making them valuable for large population screenings and routine surveillance programs.

"The Asia Pacific region is expected to witness the highest growth rate during the forecast period."

The Asia Pacific is set to experience the highest growth in the veterinary infectious disease diagnostics market due to various demographic, economic, and healthcare factors. The region's large livestock population drives the demand for accurate diagnostics to address rising infectious diseases like foot-and-mouth disease and avian influenza. Additionally, the increasing number of companion animals, especially in urban areas of China and India, is boosting veterinary healthcare spending. Enhanced veterinary infrastructure, heightened awareness of zoonotic threats, and investments in animal health are also contributing to market growth. Companies are expanding their presence in the region to improve access to advanced diagnostic technologies.

Breakdown of supply-side primary interviews:

By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

By End User: Veterinary Reference Laboratories (40%), Veterinary Hospitals & Clinics (25%), POC/In-house Testing (20%), and Veterinary Research Institutes & Universities (15%)
By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Research Coverage

The market study covers the veterinary infectious disease diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

Analysis of key drivers (growth in companion animal population, increasing demand for animal-derived food products, growing concerns about infectious zoonotic diseases, rising demand for pet insurance and growing animal health expenditures, increasing number of veterinary practitioners and rising income levels in developed markets, and growing focus on disease control and prevention measures), restraints (rising pet care costs and high cost of veterinary diagnostic tests), opportunities (growth potential of emerging economies and integration of AI and ML), and challenges (low animal healthcare awareness in emerging countries and shortage of veterinary practitioners in emerging economies) influencing the growth of the veterinary infectious disease diagnostics market.
Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the veterinary infectious disease diagnostics market.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary infectious disease diagnostic products across regions.
Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary infectious disease diagnostics market.
Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary infectious disease diagnostics market.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
- 2.2.1 SECONDARY RESEARCH
  - 2.2.1.1 Key data from secondary sources
- 2.2.2 PRIMARY DATA
  - 2.2.2.1 Key data from primary sources
  - 2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
- 2.3.1 BOTTOM-UP APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 RESEARCH ASSUMPTIONS
2.7 RISK ASSESSMENT
2.8 RESEARCH LIMITATIONS
- 2.8.1 METHODOLOGY-RELATED LIMITATIONS
- 2.8.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2024)
4.3 INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGIONAL MIX
4.4 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

5.1 MARKET DYNAMICS
- 5.1.1 DRIVERS
  - 5.1.1.1 Growth in companion animal population
  - 5.1.1.2 Increasing demand for animal-derived food products
  - 5.1.1.3 Growing concerns about infectious zoonotic diseases
  - 5.1.1.4 Rising demand for pet insurance and growing animal health expenditure
  - 5.1.1.5 Increasing number of veterinary practitioners and rising income levels in developed markets
  - 5.1.1.6 Growing focus on disease control & prevention measures
- 5.1.2 RESTRAINTS
  - 5.1.2.1 Rising pet care costs
  - 5.1.2.2 High cost of veterinary diagnostic tests
- 5.1.3 OPPORTUNITIES
  - 5.1.3.1 Growth potential of emerging economies
  - 5.1.3.2 Integration of AI & ML
- 5.1.4 CHALLENGES
  - 5.1.4.1 Low animal healthcare awareness in emerging countries
  - 5.1.4.2 Shortage of veterinary practitioners in emerging economies
5.2 INDUSTRY TRENDS
- 5.2.1 ADOPTION OF MULTIPLE TEST PANELS
- 5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
- 5.2.3 GROWING SCALE OF VETERINARY BUSINESSES
5.3 TECHNOLOGY ANALYSIS
- 5.3.1 KEY TECHNOLOGIES
  - 5.3.1.1 Portable instruments for POC diagnostic services
  - 5.3.1.2 Biosensor-based diagnostic systems
- 5.3.2 ADJACENT TECHNOLOGIES
  - 5.3.2.1 Wearable biosensors & remote monitoring devices
  - 5.3.2.2 Rapid & sensitive veterinary diagnostic kits
  - 5.3.2.3 Breath & saliva-based diagnostic tools
  - 5.3.2.4 Microfluidics & Lab-on-a-chip devices
- 5.3.3 COMPLEMENTARY TECHNOLOGIES
  - 5.3.3.1 AI-driven diagnostic platforms
  - 5.3.3.2 Next-generation sequencing (NGS)
5.4 PORTER'S FIVE FORCES ANALYSIS
- 5.4.1 THREAT OF NEW ENTRANTS
- 5.4.2 THREAT OF SUBSTITUTES
- 5.4.3 BARGAINING POWER OF SUPPLIERS
- 5.4.4 BARGAINING POWER OF BUYERS
- 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 REGULATORY ANALYSIS
- 5.5.1 REGULATORY LANDSCAPE
- 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  - 5.5.2.1 North America
  - 5.5.2.2 Europe
  - 5.5.2.3 Rest of the World
5.6 PATENT ANALYSIS
- 5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
- 5.6.2 JURISDICTION & TOP APPLICANT ANALYSIS
5.7 TRADE ANALYSIS
- 5.7.1 TRADE DATA FOR HS CODE 9018
  - 5.7.1.1 Import data for HS Code 9018
  - 5.7.1.2 Export data for HS Code 9018
5.8 PRICING ANALYSIS
- 5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022-2024
- 5.8.2 AVERAGE SELLING PRICE, BY REGION, 2022-2024
  - 5.8.2.1 Average selling price of ELISA and PCR test kits, by region, 2024
  - 5.8.2.2 Average selling price trend of ELISA test kits (per 96-well kit), by region, 2022-2024
  - 5.8.2.3 Average selling price trend of lateral flow rapid tests (per unit), by region, 2022-2024
  - 5.8.2.4 Average selling price trend of PCR test kits (veterinary panels), by region, 2022-2024
  - 5.8.2.5 Average selling price trend of immunoassay analyzers (benchtop), by region, 2022-2024
  - 5.8.2.6 Average selling price trend of high-end immunoassay analyzers, by region, 2022-2024
  - 5.8.2.7 Average selling price trend of nucleic acid sequencers (benchtop), by region, 2022-2024
5.9 REIMBURSEMENT ANALYSIS
5.10 KEY CONFERENCES & EVENTS, 2025-2026
5.11 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.11.2 BUYING CRITERIA
5.12 END-USER PERSPECTIVE & UNMET NEEDS
5.13 IMPACT OF AI ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
- 5.13.1 INTRODUCTION
- 5.13.2 MARKET POTENTIAL IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS ECOSYSTEM
- 5.13.3 AI USE CASES
- 5.13.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
5.14 ECOSYSTEM ANALYSIS
5.15 VALUE CHAIN ANALYSIS
5.16 SUPPLY CHAIN ANALYSIS
5.17 ADJACENT MARKET ANALYSIS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF 2025 US TARIFF ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
- 5.19.1 INTRODUCTION
- 5.19.2 KEY TARIFF RATES
- 5.19.3 PRICE IMPACT ANALYSIS
- 5.19.4 IMPACT ON COUNTRY/REGION
- 5.19.5 IMPACT ON END-USE INDUSTRIES

6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 CONSUMABLES
- 6.2.1 RECURRENT PURCHASE OF DIAGNOSTIC KITS AND REAGENTS TO BOOST MARKET GROWTH
6.3 INSTRUMENTS
- 6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO SUPPORT MARKET GROWTH

7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY

7.1 INTRODUCTION
7.2 IMMUNODIAGNOSTICS
- 7.2.1 LATERAL FLOW ASSAYS
  - 7.2.1.1 Lateral flow rapid tests
    - 7.2.1.1.1 Ability to provide real-time insights to drive market
  - 7.2.1.2 Lateral flow strip readers
    - 7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption
- 7.2.2 ELISA TESTS
  - 7.2.2.1 Cost-effectiveness and ease of use to drive market
- 7.2.3 IMMUNOASSAY ANALYZERS
  - 7.2.3.1 High sensitivity & specificity for biomarker detection to drive market
- 7.2.4 OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
7.3 MOLECULAR DIAGNOSTICS
- 7.3.1 PCR TESTS
  - 7.3.1.1 Increased laboratory usage in proteomics & genomics to support growth
- 7.3.2 NUCLEIC ACID SEQUENCING
  - 7.3.2.1 Growing use of nucleic acid sequencing to identify pathogens to fuel market
- 7.3.3 MICROARRAYS
  - 7.3.3.1 Growing applications of biochips in identifying infectious diseases to drive market
- 7.3.4 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
7.4 OTHER TECHNOLOGIES

8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE

8.1 INTRODUCTION
8.2 COMPANION ANIMALS
- 8.2.1 COMPANION ANIMALS MARKET, BY ANIMAL TYPE
  - 8.2.1.1 Dogs
    - 8.2.1.1.1 High insurance coverage for dogs and rising disposable incomes to drive market
  - 8.2.1.2 Cats
    - 8.2.1.2.1 Growing pet cat population to support growth
  - 8.2.1.3 Horses
    - 8.2.1.3.1 Growing equine health awareness to drive market
  - 8.2.1.4 Other companion animals
- 8.2.2 COMPANION ANIMALS MARKET, BY TECHNOLOGY
  - 8.2.2.1 Immunodiagnostics
    - 8.2.2.1.1 Lateral flow assays
      - 8.2.2.1.1.1 Rapid results, no requirement for multiple sample batches, and ease of visual reading to drive market growth
    - 8.2.2.1.2 ELISA tests
      - 8.2.2.1.2.1 High sensitivity, specificity, and precision of ELISA tests to drive market
    - 8.2.2.1.3 Immunoassay analyzers
      - 8.2.2.1.3.1 Ability to process multiple samples to drive adoption of immunoassay analyzers
    - 8.2.2.1.4 Other immunodiagnostic technologies
  - 8.2.2.2 Molecular diagnostics
    - 8.2.2.2.1 PCR tests
      - 8.2.2.2.1.1 Extensive use of PCR due to its high specificity and sensitivity to boost adoption
    - 8.2.2.2.2 Nucleic acid sequencing
      - 8.2.2.2.2.1 Increasing use of nucleic acid sequencing for pathogen discovery and identification to support growth
    - 8.2.2.2.3 Microarrays
      - 8.2.2.2.3.1 Technological advancements and increasing incidence of infectious diseases to fuel demand for microarrays
    - 8.2.2.2.4 Other molecular diagnostic technologies
  - 8.2.2.3 Other technologies
8.3 LIVESTOCK
- 8.3.1 LIVESTOCK MARKET, BY ANIMAL TYPE
  - 8.3.1.1 Cattle
    - 8.3.1.1.1 Growing consumption of meat to support market growth
  - 8.3.1.2 Pigs
    - 8.3.1.2.1 Growing incidence of infectious diseases to drive market
  - 8.3.1.3 Poultry
    - 8.3.1.3.1 Increasing demand for poultry meat to contribute to market growth
  - 8.3.1.4 Other livestock
- 8.3.2 LIVESTOCK MARKET, BY TECHNOLOGY
  - 8.3.2.1 Immunodiagnostics
    - 8.3.2.1.1 Lateral flow assays
      - 8.3.2.1.1.1 Field-readiness and stakeholder accessibility of LFAs to boost demand
    - 8.3.2.1.2 ELISA tests
      - 8.3.2.1.2.1 Cost-effectiveness, high sensitivity, and ease of use to drive ELISA market
    - 8.3.2.1.3 Immunoassay analyzers
      - 8.3.2.1.3.1 High sensitivity & specificity for biomarker detection to drive market
    - 8.3.2.1.4 Other immunodiagnostic technologies
  - 8.3.2.2 Molecular diagnostics
    - 8.3.2.2.1 PCR tests
      - 8.3.2.2.1.1 Growing use of PCR in proteomics and genomics to drive market growth
    - 8.3.2.2.2 Nucleic acid sequencing
      - 8.3.2.2.2.1 Identification of pathogens to fuel market
    - 8.3.2.2.3 Microarrays
      - 8.3.2.2.3.1 Emergence of biochips and growing applications in identifying infectious diseases to drive growth
    - 8.3.2.2.4 Other molecular diagnostic technologies
  - 8.3.2.3 Other technologies

9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER

9.1 INTRODUCTION
9.2 VETERINARY REFERENCE LABORATORIES
- 9.2.1 LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET
9.3 VETERINARY HOSPITALS & CLINICS
- 9.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET
9.4 POINT-OF-CARE/IN-HOUSE TESTING
- 9.4.1 COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND
9.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
- 9.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH

10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
  - 10.2.2.1 High veterinary healthcare expenditure to drive market
- 10.2.3 CANADA
  - 10.2.3.1 Growing pet adoption to drive market
10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
  - 10.3.2.1 Rising awareness of zoonotic diseases to fuel market
- 10.3.3 UK
  - 10.3.3.1 Increasing pet ownership to drive market
- 10.3.4 FRANCE
  - 10.3.4.1 Willingness of pet owners to spend on pet health to drive market
- 10.3.5 ITALY
  - 10.3.5.1 Growing consumption of meat & dairy products to drive market
- 10.3.6 SPAIN
  - 10.3.6.1 Growing demand for poultry products to fuel market
- 10.3.7 NETHERLANDS
  - 10.3.7.1 Developments in veterinary diagnostic products to support market growth
- 10.3.8 REST OF EUROPE
10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
  - 10.4.2.1 Increasing incidence of zoonotic diseases to propel market
- 10.4.3 JAPAN
  - 10.4.3.1 Increasing pet expenditure to support market growth
- 10.4.4 INDIA
  - 10.4.4.1 Increasing demand for dairy products to drive market
- 10.4.5 AUSTRALIA
  - 10.4.5.1 Rise in pet ownership to support market growth
- 10.4.6 SOUTH KOREA
  - 10.4.6.1 Rising need for specialized veterinary services to drive market
- 10.4.7 NEW ZEALAND
  - 10.4.7.1 Focus on pet insurance to aid market
- 10.4.8 VIETNAM
  - 10.4.8.1 Growing focus on disease surveillance to drive market
- 10.4.9 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
  - 10.5.2.1 Growth in livestock industry to boost demand
- 10.5.3 MEXICO
  - 10.5.3.1 Increasing focus on poultry-associated products to support market growth
- 10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 10.6.2 GCC COUNTRIES
  - 10.6.2.1 Kingdom of Saudi Arabia (KSA)
    - 10.6.2.1.1 Technological advancements in veterinary diagnostics to boost demand
  - 10.6.2.2 United Arab Emirates (UAE)
    - 10.6.2.2.1 Favorable government support for vet diagnostics to drive market
  - 10.6.2.3 Rest of GCC Countries
- 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.3 REVENUE ANALYSIS, 2020-2024
11.4 MARKET SHARE ANALYSIS, 2024
- 11.4.1 MARKET SHARE ANALYSIS FOR COMPANION ANIMALS
- 11.4.2 MARKET SHARE ANALYSIS FOR LIVESTOCK
- 11.4.3 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 11.5.5.1 Company footprint
  - 11.5.5.2 Region footprint
  - 11.5.5.3 Product footprint
  - 11.5.5.4 Technology footprint
  - 11.5.5.5 Animal type footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  - 11.6.5.1 Detailed list of key startups/SMEs
  - 11.6.5.2 Competitive benchmarking of key startups
11.7 BRAND/PRODUCT COMPARISON
11.8 R&D EXPENDITURE OF KEY PLAYERS
11.9 COMPANY VALUATION & FINANCIAL METRICS
- 11.9.1 FINANCIAL METRICS
- 11.9.2 COMPANY VALUATION
11.10 COMPETITIVE SCENARIO
- 11.10.1 PRODUCT LAUNCHES & ENHANCEMENTS
- 11.10.2 DEALS
- 11.10.3 EXPANSIONS
- 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

12.1 KEY PLAYERS
- 12.1.1 IDEXX LABORATORIES, INC.
  - 12.1.1.1 Business overview
  - 12.1.1.2 Products & services offered
  - 12.1.1.3 Recent developments
    - 12.1.1.3.1 Product/Service launches & enhancements
  - 12.1.1.4 MnM view
    - 12.1.1.4.1 Key strengths
    - 12.1.1.4.2 Strategic choices
    - 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 ZOETIS SERVICES LLC
  - 12.1.2.1 Business overview
  - 12.1.2.2 Products & services offered
  - 12.1.2.3 Recent developments
    - 12.1.2.3.1 Product enhancements
    - 12.1.2.3.2 Deals
    - 12.1.2.3.3 Expansions
  - 12.1.2.4 MnM view
    - 12.1.2.4.1 Key strengths
    - 12.1.2.4.2 Strategic choices
    - 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 THERMO FISHER SCIENTIFIC INC.
  - 12.1.3.1 Business overview
  - 12.1.3.2 Products & services offered
  - 12.1.3.3 MnM view
    - 12.1.3.3.1 Key strengths
    - 12.1.3.3.2 Strategic choices
    - 12.1.3.3.3 Weaknesses & competitive threats
- 12.1.4 VIRBAC
  - 12.1.4.1 Business overview
  - 12.1.4.2 Products & services offered
  - 12.1.4.3 Recent developments
    - 12.1.4.3.1 Deals
    - 12.1.4.3.2 Expansions
  - 12.1.4.4 MnM view
    - 12.1.4.4.1 Key strengths
    - 12.1.4.4.2 Strategic choices
    - 12.1.4.4.3 Weaknesses & competitive threats
- 12.1.5 BIOMERIEUX
  - 12.1.5.1 Business overview
  - 12.1.5.2 Products & services offered
  - 12.1.5.3 Recent developments
    - 12.1.5.3.1 Product launches & approvals
  - 12.1.5.4 MnM view
    - 12.1.5.4.1 Key strengths
    - 12.1.5.4.2 Strategic choices
    - 12.1.5.4.3 Weaknesses & competitive threats
- 12.1.6 ANTECH DIAGNOSTICS, INC.
  - 12.1.6.1 Business overview
  - 12.1.6.2 Products & services offered
  - 12.1.6.3 Recent developments
    - 12.1.6.3.1 Product launches
    - 12.1.6.3.2 Expansions
- 12.1.7 INNOVATIVE DIAGNOSTICS
  - 12.1.7.1 Business overview
  - 12.1.7.2 Products & services offered
- 12.1.8 NEOGEN CORPORATION
  - 12.1.8.1 Business overview
  - 12.1.8.2 Products & services offered
    - 12.1.8.2.1 Other developments
- 12.1.9 INDICAL BIOSCIENCE GMBH
  - 12.1.9.1 Business overview
  - 12.1.9.2 Products & services offered
  - 12.1.9.3 Recent developments
    - 12.1.9.3.1 Product enhancements
- 12.1.10 AGROLABO S.P.A.
  - 12.1.10.1 Business overview
  - 12.1.10.2 Products & services offered
- 12.1.11 BIONOTE
  - 12.1.11.1 Business overview
  - 12.1.11.2 Products & services offered
  - 12.1.11.3 Recent developments
  - 12.1.11.4 Product launches
    - 12.1.11.4.1 Deals
- 12.1.12 BIOGAL
  - 12.1.12.1 Business overview
  - 12.1.12.2 Products & services offered
- 12.1.13 BIOCHEK
  - 12.1.13.1 Business overview
  - 12.1.13.2 Products & services offered
  - 12.1.13.3 Recent developments
    - 12.1.13.3.1 Product launches
    - 12.1.13.3.2 Deals
- 12.1.14 MEGACOR DIAGNOSTIK GMBH
  - 12.1.14.1 Business overview
  - 12.1.14.2 Products & services offered
  - 12.1.14.3 Recent developments
    - 12.1.14.3.1 Product launches & enhancements
- 12.1.15 BIO-RAD LABORATORIES, INC.
  - 12.1.15.1 Business overview
  - 12.1.15.2 Products & services offered
12.2 OTHER PLAYERS
- 12.2.1 FASSISI, GMBH
- 12.2.2 BIOTANGENTS LIMITED
- 12.2.3 SKYER, INC.
- 12.2.4 BIOPANDA REAGENTS LTD.
- 12.2.5 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
- 12.2.6 GOLD STANDARD DIAGNOSTICS
- 12.2.7 BIO-X DIAGNOSTICS S.A.
- 12.2.8 DEMEDITEC DIAGNOSTICS GMBH
- 12.2.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
- 12.2.10 BIOSTONE ANIMAL HEALTH

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 RELATED REPORTS
13.4 AUTHOR DETAILS

動物用感染症診断薬の世界市場：製品別、技術別、動物タイプ別、エンドユーザー別、地域別 - 2030年までの予測

Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030

目次

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章重要考察

第5章市場概要

第6章動物用感染症診断薬市場（製品別）

第7章動物用感染症診断薬市場（技術別）

第8章動物用感染症診断薬市場（動物タイプ別）

第9章動物用感染症診断薬市場（エンドユーザー別）

第10章動物用感染症診断薬市場（地域別）

第11章競合情勢

第12章企業プロファイル

第13章付録

List of Tables

List of Figures

Breakdown of supply-side primary interviews:

Breakdown of demand-side primary interviews:

This report provides insights into the following points:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT

7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY

8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE

9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER

10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

動物用感染症診断薬の世界市場：製品別、技術別、動物タイプ別、エンドユーザー別、地域別 - 2030年までの予測

Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

第6章 動物用感染症診断薬市場（製品別）

第7章 動物用感染症診断薬市場（技術別）

第8章 動物用感染症診断薬市場（動物タイプ別）

第9章 動物用感染症診断薬市場（エンドユーザー別）

第10章 動物用感染症診断薬市場（地域別）

第11章 競合情勢

第12章 企業プロファイル

第13章 付録

List of Tables

List of Figures

Breakdown of supply-side primary interviews:

Breakdown of demand-side primary interviews:

This report provides insights into the following points:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT

7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY

8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE

9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER

10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章重要考察

第5章市場概要

第6章動物用感染症診断薬市場（製品別）

第7章動物用感染症診断薬市場（技術別）

第8章動物用感染症診断薬市場（動物タイプ別）

第9章動物用感染症診断薬市場（エンドユーザー別）

第10章動物用感染症診断薬市場（地域別）

第11章競合情勢

第12章企業プロファイル

第13章付録